After a 54% year-over-year sales…
After a 54% year-over-year sales increase for CGRP migraine drug [...]
Nearly a year after earning the…
Nearly a year after earning the first-ever FDA approval for [...]
U.S. District Judge Gregory…
U.S. District Judge Gregory Williams concluded that two patents held [...]
The FDA has approved a treatment…
The FDA has approved a treatment for recurrent respiratory papillomatosis [...]
The combination of Padcev and…
The combination of Padcev and Keytruda delivered a phase 3 [...]
Eli Lilly said it has “intensified…
Eli Lilly said it has “intensified efforts to align prices across [...]
An analysis of how cancer…
An analysis of how cancer drugmakers interact with oncologists found, [...]
Generic versions of CSL’s iron…
Generic versions of CSL’s iron replacement therapy Venofer have arrived [...]
The National Advertising Division…
The National Advertising Division has sided with Genomic Health in [...]
Vor Bio’s big bet on RemeGen’s…
Vor Bio’s big bet on RemeGen’s autoimmune asset telitacicept appears [...]